Moderna Inc has begun testing its Covid-19 vaccine on children and infants between the ages of six months and 12-year-old in a study, as the pharmaceutical company seeks to expand approval for its vaccine to children, the company said on Tuesday. The phase 2-phase 3 trial is being conducted in conjunction with the National Institute … Continue reading Moderna begins testing of Covid-19 vaccine on children